Interferon alpha 2a in patients of chronic hepatitis C
Zuberi, S.J.; Alam, S.E.; Raza, S.
Jpma. Journal of the Pakistan Medical Association 44(7): 171-172
1994
ISSN/ISBN: 0030-9982 PMID: 7933458 Document Number: 427647
Document emailed within 1 workday
Related Documents
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Rabinovitz, M.; Block, G.; Finkelstein, S.D. 1996: Alpha-Interferon retreatment of patients with chronic hepatitis C American Journal of Gastroenterology 91(8): 1523-1526
Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G. 1993: Selection of patients with chronic hepatitis B for therapy with alpha-interferon Zeitschrift für Arztliche Fortbildung 87(4): 273-278
Bruguera, M.; Sánchez Tapias, J.M. 1991: Interferon-alpha. a good treatment for some patients with chronic hepatitis B Medicina Clinica 97(18): 697-699
Pawłowska, M.łg.; Halota, W. 2006: Pegylated interferon alpha in the treatment of chronic hepatitis B in HBe negative patients Przeglad Epidemiologiczny 60(1): 105-108
Alagiozian-Angelova, V.; Alagiozian, D.; Lyutakova, E.; Grigorov, L. 1998: Endogenous serum interferon-alpha in patients with chronic hepatitis B virus infection Folia Medica 40(3): 71-75
Laghi, V.; Toccaceli, F.; Rosati, S.; Monini, A.; Grimaldi, M.; Foglianti, G.; Canova, N.; Palazzini, E. 1997: Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C Hepato-Gastroenterology 44(16): 1182-1186
Łapiński, T.W. 2001: Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 138-142
Di Marco, V.; Lo Iacono, O.; Capra, M.; Grutta, S.; Ciaccio, C.; Gerardi, C.; Maggio, A.; Renda, D.; Almasio, P.; Pisa, R. 1992: alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia Haematologica 77(6): 502-506
Husa, P.; Husova, L. 2001: Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons Bratislavske Lekarske Listy 102(5): 248-252
Minelli, R.; Coiro, V.; Valli, M.Antonietta.; Finardi, L.; Di Seclì, C.; Bertoni, R.; La Gioia, D.; Barilli, A.Luciana.; Ferrari, C.; Jotti, G.Saccani.; Delsignore, R. 2005: Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 53(1): 26-30
Rocco, A.; Gargano, S.; Provenzano, A.; Nardone, M.; De Sanctis, G.M.; Altavilla, N.; Chircu, L.V.; Grimaldi, F. 2001: Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection Neuro Endocrinology Letters 22(1): 39-44
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Moulin, V.; Harzic, M.; Doll, J.; Dubeaux, B.; Ghnassia, J.C.; Andrieu, J. 1996: Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C Pathologie-Biologie 44(5): 468-472
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Czarnywojtek, A.; Waligórska-Stachura, J.; Szczepanek, E.; Zgorzalewicz-Stachowiak, M.łg.; Bereszyńska, I.; Kurdybacha, P.; Stangierski, A.; Harasymczuk, J.; Florek, E.; Waśko, R.; Ruchała, M. 2012: A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine Neuro Endocrinology Letters 33(3): 268-272
Durante-Mangoni, E.; Iardino, P.; Utili, R.; Adinolfi, L.E.; Ruggiero, G. 2006: Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts Antiviral Therapy 11(5): 637-640